Tančić-Gajić M, Vujović S, Vukčević M, Ivović M, Drezgić M, Marina Lv, Stojanović M, Arizanović Z, Nenezić A, Micić D
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Serbia.
Hippokratia. 2012 Oct;16(4):335-41.
Weight loss improves the metabolic syndrome (MetS) features and related clinical abnormalities in obese subjects. The aim of this study was to assess the effects of a non-surgical therapeutic program on the MetS in severely obese patients.
Sixty-four extremely obese patients were involved in the therapeutic program, which consisted of two alternating phases: the three-week therapeutic fasting or semi-fasting in hospital conditions and the low calorie diet with dosed physical activity in outpatient conditions. At the baseline we measured: anthropometric parameters, blood pressure and lipid profile. Subjects underwent an oral glucose tolerance test and insulin resistance/sensitivity was evaluated by the homeostasis model assessment and the oral glucose insulin sensitivity. After weight reduction by at least 10%, all mentioned assessments were repeated.
None of the patients had significant adverse effects. Forty-one patients aged 43.0±11.5 years completed the study. The mean weight loss was 27 kg or 18% of the initial weight (p<0.01), which was followed by a significant decrease of the insulin resistance, the overall prevalence of MetS (32%) and all MetS parameters, without the significant change in high-density lipoprotein. This weight loss pogram substantially improves the MetS in extremely obese patients.
The tailored alternating either fasting or semi- fasting should be considered as an optional approach to manage extreme obesity and related metabolic abnormality.
体重减轻可改善肥胖受试者的代谢综合征(MetS)特征及相关临床异常情况。本研究旨在评估一项非手术治疗方案对重度肥胖患者代谢综合征的影响。
64例极度肥胖患者参与了该治疗方案,该方案包括两个交替阶段:在医院条件下进行为期三周的治疗性禁食或半禁食,以及在门诊条件下进行低热量饮食并搭配定量体育活动。在基线时,我们测量了人体测量参数、血压和血脂谱。受试者接受口服葡萄糖耐量试验,并通过稳态模型评估和口服葡萄糖胰岛素敏感性评估胰岛素抵抗/敏感性。体重减轻至少10%后,重复所有上述评估。
所有患者均未出现明显不良反应。41例年龄为43.0±11.5岁的患者完成了研究。平均体重减轻27 kg,占初始体重的18%(p<0.01),随后胰岛素抵抗、代谢综合征的总体患病率(32%)以及所有代谢综合征参数均显著降低,高密度脂蛋白无显著变化。这种体重减轻方案显著改善了极度肥胖患者的代谢综合征。
应将定制的交替禁食或半禁食视为管理极度肥胖及相关代谢异常的一种可选方法。